Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk

Project: Research project

Project Details

StatusActive
Effective start/end date12/15/2311/30/25

Funding

  • ImmunoChem Therapeutics, LLC (Award Letter - 03/04/2024 // 4R44AG071062-02)
  • National Institute on Aging (Award Letter - 03/04/2024 // 4R44AG071062-02)